Krakauer, MarcioGómez, Ana M.Almeda-Valdes, PalomaManrique, HelardRuiz Morosini, María LidiaGodoy Jorquera, GonzaloNunes Salles, João EduardoSanhueza Costa, Davidde Azeredo Siqueira, RodrigoFaradji, Raquel N.Rincón Ramírez, AlexRé, Matías2025-04-232025-04-232024-12Diabetology and Metabolic Syndrome Volume 16, Issue 1 December 2024 Article number 1061758-5996https://repositorio.unab.cl/handle/ria/64257Indexación (Scopus)Objective: To establish recommendations through the consensus of a Latin American experts panel on the use of the flash glucose monitoring system (fCGM) in people living with type 2 diabetes mellitus (T2DM) regarding the benefits and challenges of using the fCGM. Methods: An executive committee of experts was created, comprised by a panel of fifteen physicians, including endocrinologists and internal medicine physicians, with expertise in management of adult patients with T2DM. The experts were from various countries: Colombia, Chile, Peru, Mexico, Argentina, and Brazil. The modified Delphi method was used, considering a consensus level of at least 80% of the participants. A seventeen-item instrument was developed to establish recommendations on the use of fCGM in patients with T2DM in Latin American. Results: The number of glucose scans recommended per day with the fCGM for patients managed with oral antidiabetic drugs or basal insulin was a median of 6 scans per day, and for those managed with multiple insulin doses, a median of 10 scans per day was recommended. Additionally, a holistic and individualized management approach was recommended, taking into account new treatment directions and identifying patients who would benefit from the use of the fCGM. Conclusion: Continuous use of the fCGM is recommended for people living with T2DM, regardless of their type of treatment. These metrics must be evaluated individually for each patient profile.en-USConsensusFlash Continuous Glucose Monitoring SystemType 2 DiabetesArtículoAtribución/Reconocimiento 4.0 Internacional10.1186/s13098-024-01343-7